Skip to main content

Cefprozil Pregnancy and Breastfeeding Warnings

Cefprozil is also known as: Cefzil

Medically reviewed by Last updated on Jan 4, 2021.

Cefprozil Pregnancy Warnings

Cefprozil has been assigned to pregnancy category B by the FDA. Animal data failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Cefprozil should only be given during human pregnancy when need has been clearly established.

See references

Cefprozil Breastfeeding Warnings

Cefprozil is excreted into human milk in small amounts (0.3% of a 1 gram dose). Average milk levels were between 0.25 to 3.3 mcg/mL over 24 hours. The American Academy of Pediatrics has classified cefprozil as compatible with breast-feeding. The manufacturer recommends that caution be used when administering cefprozil to nursing women.

See references

References for pregnancy information

  1. "Product Information. Cefzil (cefprozil)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Cefzil (cefprozil)." Bristol-Myers Squibb, Princeton, NJ.
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.